Combined use of Anlotinib with chemotherapy in patients with advanced ovarian cancer: a real-world cohort study and meta-analysis.
XinYi HongShanHu QiuBo DingHao XuYang ShenPublished in: Therapeutic advances in medical oncology (2024)
The combined use of Anlotinib with chemotherapy showed potential in treating patients with advanced ovarian cancer, with a tolerable safety profile.